Pharmaceutical Care on Alcoholic Liver Disease

A study on patients with alcoholic liver disease and to assess impact of pharmaceutical care on related quality of life patients with alcoholic liver disease was conducted. A prospective single centered randomized study was carried out to determine the impact of pharmaceutical care on related quality of life of patients with alcoholic liver disease for a period of six months. The study included in-patients as well as out-patients treated in the General Medicine and psychiatry department who were suffering from alcoholic liver disease. While using self-questionnaires: socio demographic questionnaires of the competence network bowel disease, morbidity list of the German pain questionnaire the German version of the medical outcome study 36 item short form health survey SF(Short Form)-36. The study revealed that out of 104 patients, who were divided as study group and control group the study group (52patients) with alcoholic liver disease who were given pharmaceutical care are beneficiated in improving related quality of life. Results: The study showed that there is statistical significance in overall health-related quality of life of alcoholic liver disease patients.